Print Page  Close Window

Press Releases
Keyword Search
2018 | 2017 | 2016 | 2015 | 2014
03.14.18Zynerba Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare ConferencePrinter Friendly Version
03.12.18Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Operational HighlightsPrinter Friendly Version
03.05.18Zynerba Pharmaceuticals Announces Positive Meeting with U.S. Food and Drug Administration and Plans to Conduct a Single Pivotal Study of ZYN002 in Fragile X Syndrome to Support an NDA FilingPrinter Friendly Version
01.03.18Zynerba Pharmaceuticals Provides 2018 Clinical and Corporate UpdatePrinter Friendly Version